麗江股份(002033.SZ):瀘沽湖摩梭小鎮二期項目計劃於2024年建成並投入運營
格隆匯5月12日丨麗江股份(002033.SZ)於2023年5月11日(週四)上午10:30~12:00召開業績説明會,就“瀘沽湖摩梭小鎮二期項目的主要內容是什麼?預計完成時間是什麼?與瀘沽湖一期項目相比,有哪些新的亮點和特色?”,公司回覆稱,摩梭小鎮二期建設工程主要包括瀘沽湖英迪格酒店、摩梭宮沉浸式演藝、希爾頓歡朋酒店和摩梭風情休閒街等。二期項目計劃於2024年建成並投入運營。與瀘沽湖一期項目相比進一步豐富了旅遊業態,增加了旅遊文化演藝、文旅休閒商業、國際品牌度假酒店等,豐富了遊客的旅遊體驗,二期工程建成將初步實現摩梭小鎮主體項目的整體運營。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.